Health Trials

Lymphoma, B-Cell, Marginal Zone

2

Review clinical trials related to Lymphoma, B-Cell, Marginal Zone. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies. Participants will have the option to continue taking LY4152199 until the study ends.

Participants needed: 215
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Eli Lilly and CompanyUpdated: Jun 23, 2026Locations: 50
Eligibility criteria

Must have a diagnosis of either follicular lymphoma or diffuse large B-cell lymp... [+6]

Known or suspected peripheral blood involvement by malignant cells with an absol... [+15]

Read more
Status: Not yet recruiting

A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

This is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with relapsed/refractory (R/R) B-cell malignancies.

Participants needed: 69
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Cancer Institute and Hospital, Chinese Academy of Medical SciencesUpdated: Mar 17, 2026Locations: 1
Eligibility criteria

Male or female, aged 18 - 75 years old (inclusive); [+12]

B-NHL participants with a history of Richter's transformation of chronic lymphoc... [+15]

Read more